By Geoff Cockrell, Steven Keeler and Clare Lewis

Earlier in the year, CB Insights reported that the syndicate patterns of the most active tech VC investors revealed a host of co-investor relationships, overlapping investing strategies and/or geographic focus areas. In this article, CB Insights examines the top investment syndicate partners of 2013′s most active healthcare VCs. With the healthcare market seeing a big year on the IPO front in 2013, there were number of active venture capital investors pursuing deals in healthcare. Versant Ventures, New Enterprise Associates, and Domain Associates (which was among the top healthcare VCs ranked by 2013 IPOs) topped the list of most active U.S.-based VCs in the healthcare sector. The most active healthcare venture capital investors also included: Polaris Partners, OrbiMed Advisors, SV Life Sciences, MPM Capital, Arch Venture Partners, Kleiner Perkins Caufield & Byers and InterWest Partners.

Similar to the most active tech VCs, healthcare’s most active investors also see a presence of corporate venture arms among their top syndicate partners including Johnson & Johnson Development Corporation and GlaxoSmithKline’s SR One. The article highlights the most frequent co-investment partners in 2013 of each of the 10 most active healthcare VCs identified, and also reveals several co-investment relationships with the healthcare investment arms of PE firms and mutual funds including TPG Biotech and Fidelity Biosciences.[1] 

[1] CB Insights, The Most Frequent Investment Syndicate Partners of 2013′s Most Active Healthcare VCs, January 24, 2014